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Superior vena cava (SVC) reconstruction is occasionally required in the treatment of benign and malignant
conditions. We report a patient with symptomatic SVC obstruction secondary to mediastinal fibrosis successfully
reconstructed with an aortic allograft.
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Many techniques have been described for SVC recon-
struction including the use of spiral saphenous vein, au-
tologous and bovine pericardium, and vascular prostheses,
such as externally stented polytetraflouroethylene grafts.
Due to wall compliance consistent with vascular tissue, su-
perior handling characteristics, and low thrombogenicity,
human cryopreserved arterial allografts have recently been
utilized for SVC reconstruction following resection for
malignancy [1-3]. We report a patient with symptomatic
SVC obstruction secondary to mediastinal fibrosis suc-
cessfully treated with resection and reconstruction using a
thoracic aortic allograft.Case presentation
The patient is a 47-year-old African-American male who
presented with worsening syncope, brachiocephalic swell-
ing, and dyspnea. Contrast computed tomography (CT)
demonstrated near total obliteration of the SVC at the level
of the right pulmonary artery with an area of soft tissue cal-
cification consistent with remote granulomatous infection.
(Figure 1A) The obstruction was felt unamenable to percu-
taneous intervention therefore SVC resection and recon-
struction planned through a median sternotomy approach.
Intraoperatively, large subcutaneous and mediastinal collat-
eral veins were encountered. Circumferential dissection of
both innominate veins was ultimately accomplished just
proximal to the confluence and the intrapericardial SVC* Correspondence: kkesler@iupui.edu
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reproduction in any medium, provided the orcarefully sparing the right phrenic nerve. The azygous vein
appeared chronically occluded within the area of fibrosis.
Intravenous heparin (100 U/kg) was given and after 3 mi-
nutes, both innominate veins and the intrapericardial SVC
were clamped one centimeter above the sino-atrial node
region. The SVC was divided through the fibrotic tissue
and a residual lumen of approximately 1 to 2 mm noted.
The SVC and surrounding fibrotic tissue were excised
proximally and distally back to normal vessel again with
careful preservation of the phrenic nerve, which totaled
an approximate 4 to 5 cm segment. Superior vena cava
reconstruction was then accomplished using a 16 mm
cryopreserved ascending aortic allograft ABO/HLA un-
matched (Cryolife Inc, Atlanta, GA). The aortic valve
was excised at the top of the commissures, then a prox-
imal end-to-end anastomosis established between the
conduit and the proximal SVC, just distal to the innomin-
ate confluence, using a running 5–0 polypropylene suture.
The allograft was cut to appropriate length, which excised
the curvature into the transverse aortic arch. A distal end-
to-end anastomosis was performed from the allograft to
the SVC approximately 1 cm above the SVC-right atrial
junction. Clamps were removed after de-airing to reestab-
lish flow through the homograft. (Figure 2) Subcutaneous
heparin (5,000 U) three times daily for DVT prophylaxis
and aspirin were begun on the second postoperative day.
The patient’s initial postoperative course was uneventful
with excellent relief of his symptoms. He was discharged
on the seventh postoperative day on aspirin only and re-
mains asymptomatic 12 months following surgery. Patho-
logic findings of the native SVC and surrounding tissuetd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Pre and postoperative CT images. A. Preoperative axial computed tomogram with intravenous contrast demonstrating near-total
obstruction of the SVC at the level of the right pulmonary artery (arrow). B. Postoperative coronal computed tomogram with intravenous contrast
demonstrating wide patency of the cryopreserved thoracic aortic allograft-reconstructed SVC (arrows on proximal and distal anastomoses).
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fibrosis and calcification most likely due to Histoplasmosis.
A CT scan with contrast was obtained 6 months after the
initial operation confirming patency of the thoracic aortic
allograft (Figure 1B).Figure 2 Intraoperative photograph of allograft conduit in the
anatomic SVC position (arrows on proximal and distal
anastomoses, RA = right atrial appendage, IV = left innominate
vein, PN = phrenic nerve and pedicle).Discussion
SVC reconstruction remains a surgical challenge and the
optimal method is unknown. All currently utilized methods
have limitations, the most significant of which is an inher-
ent risk of thrombosis in a low pressure/flow venous sys-
tem. We believe there are several advantages of utilizing an
allograft for SVC reconstruction. Although controversial,
the cryopreservation process of aortic allografts has been
shown to potentially diminish endothelial antigenicity with
a flow surface more resistant to inflammatory responses
and secondary clot formation when used in the arterial sys-
tem [1-3]. Long-term studies with respect to ABO/HLA
matched and unmatched vascular allografts are however
needed in this regard. Aortic allografts confer a wall com-
pliance more closely related native vascular tissue. Tissue
handling and suturing is superior as compared to other
conduits. Finally, aside from thawing, no preparation is ne-
cessary. Although the natural curvature of an ascending
aorta allograft has been used as a “bypass” conduit from the
left innominate vein to the right atrial appendage, we be-
lieve that orthotopic SVC reconstruction or direct right
innominate vein to SVC reconstruction represents an
optimal approach for patients who require resection of the
innominate vein confluence. SVC conduits routed orthoto-
pically or right innominate to SVC conduits would likely be
more physiologic and less subject to kinking from lung or
cardiac motion [4,5].
Conclusions
We believe this is the first report of an aortic allograft used
for SVC reconstruction due to symptomatic obstruction
secondary to fibrosing mediastinitis. In light of the benign
etiology, the additional expense of an allograft as compared
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justified. In this regard, either a descending thoracic or
abdominal aorta allograft, if available, may represent a
somewhat less expensive option. Based on early experience,
further study with allograft tissue for SVC/innominate vein
reconstruction is warranted for both benign and malignant
conditions.
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